Riskpilot← Back to searchSign inGet full accessAPROVIX AB
ABActiveOrg 5566086913Gårdsvägen 8Research and experimental development on natural sciences and engineering · NACE 7210Est. 20011 employees
Revenue 2024
SEK 630K
+483% vs 2023
EBITDA margin
-35.7%
+79% vs 2023
Equity ratio
6.0%
Financial strength
Net profit 2024
SEK -851K
+46% vs 2023
| Revenue | SEK 630K | +483% |
| EBITDA | SEK -225K | +79% |
| Net profit | SEK -851K | +46% |
| Total assets | SEK 1,3M | -32% |
| Equity | SEK 78K | +875% |
| Employees | 1 | — |
Legal name
APROVIX AB
Org number
5566086913
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
3 april 2001
Share capital
SEK 102 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva verksamhet inom området för medicinsk diagnostik och därmed förenlig verksamhet.
Address
Gårdsvägen 8
Phone
+46704479800
Email
info@aprovix.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 354 | 212 | 355 | 336 | 930 | 996 | 108 | 630 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −3 645 | −4 179 | −4 208 | −3 068 | −2 849 | −2 147 | −1 937 | −2 201 | −1 087 | −225 |
| Depreciation & amort. | −303 | −374 | −287 | −436 | −417 | −424 | −424 | −424 | −424 | −424 |
| EBIT | −3 948 | −4 553 | −4 495 | −3 504 | −3 266 | −2 571 | −2 361 | −2 625 | −1 511 | −649 |
| Net financials | −113 | −141 | −135 | −104 | −90 | −76 | −71 | −70 | −69 | −202 |
| Profit before tax | −4 062 | −4 694 | −4 630 | −3 608 | −3 356 | −2 647 | −2 432 | −2 695 | −1 580 | −851 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −4 062 | −4 694 | −4 630 | −3 608 | −3 356 | −2 647 | −2 432 | −2 695 | −1 580 | −851 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 231 | 3 552 | 4 681 | 4 842 | 3 972 | 3 866 | 3 224 | 2 957 | 1 914 | 1 303 |
| Equity | 375 | 461 | 1 851 | 2 018 | 1 952 | 1 585 | 850 | 540 | 8 | 78 |
| Long-term debt | 825 | 1 615 | 959 | 1 487 | 1 027 | 951 | 839 | 652 | 607 | 607 |
| Short-term debt | 2 031 | 1 476 | 1 869 | 1 337 | 994 | 1 330 | 1 535 | 1 765 | 1 300 | 618 |
| Total debt | 2 856 | 3 091 | 2 828 | 2 824 | 2 021 | 2 281 | 2 374 | 2 417 | 1 907 | 1 225 |
EBITDA margin
-35.7%
This company
15.8%
Market median
-326% vs market
20152024
Equity ratio
6.0%
This company
38.2%
Market median
-84% vs market
20152024
Return on equity
-1091.0%
This company
18.4%
Market median
-6029% vs market
20152024
Net profit margin
-135.1%
This company
8.1%
Market median
-1768% vs market
20152024
Asset turnover
0.48×
This company
1.12×
Market median
-57% vs market
20152024
Debt / equity
15.71×
This company
0.62×
Market median
-2434% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SO Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
TN Audit | Audit | 2023 | — | — |
HG Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Deputy Board Member | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of APROVIX AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Olof Mattsson | Chief Executive Officer | 0 companies |
| Tomas Nöjd | Audit | 0 companies |
| Hans Gösta Gustafsson | Chief Auditor | 0 companies |
| Leena Katriina Niemistö | Board of Directors | 0 companies |
| Josefin Christina Landgård | Board of Directors | 0 companies |
| Pia Lovisa Hennermark Engholm | Board of Directors | 0 companies |
| Nils Erik Mattias Wilander | Board of Directors | 0 companies |
| P Alexandra M De Wever Treschow | Board of Directors | 0 companies |
| Rut Malin Enocson | Deputy Board Member | 0 companies |